Goldman Sachs
ARKG icon

Goldman Sachs’s ARK Genomic Revolution ETF ARKG Stock Holding History

Goldman Sachs’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.1M Buy
+1,500,000
New +$47.8M 0.01% 1608
2025
Q3 		– Sell
-1,500,200
Closed -$36.5M – 6323
2025
Q2 		$36.5M Buy
1,500,200
+500,000
+50% +$11M 0.01% 1581
2025
Q1 		$20.8M Buy
1,000,200
+442,400
+79% +$11.1M ﹤0.01% 1993
2024
Q4 		$13.1M Hold
557,800
– – ﹤0.01% 2542
2024
Q3 		$14.3M Buy
557,800
+157,800
+39% +$4.02M ﹤0.01% 2367
2024
Q2 		$9.39M Buy
+400,000
New +$10.1M ﹤0.01% 2559
2023
Q2 		– Sell
-800,000
Closed -$24.1M – 5733
2023
Q1 		$24.1M Buy
800,000
+279,900
+54% +$8.67M 0.01% 1647
2022
Q4 		$14.7M Sell
520,100
-200,000
-28% -$6.35M ﹤0.01% 2223
2022
Q3 		$23.7M Buy
720,100
+485,100
+206% +$17.8M 0.01% 1719
2022
Q2 		$7.4M Sell
235,000
-1,499,100
-86% -$52.4M ﹤0.01% 2782
2022
Q1 		$79.6M Sell
1,734,100
-1,855,600
-52% -$88.5M 0.02% 915
2021
Q4 		$220M Buy
3,589,700
+3,574,700
+23,831% +$247M 0.04% 425
2021
Q3 		$1.12M Sell
15,000
-840,600
-98% -$70.5M ﹤0.01% 4651
2021
Q2 		$79.1M Sell
855,600
-21,200
-2% -$1.8M 0.02% 906
2021
Q1 		$77.8M Buy
876,800
+808,200
+1,178% +$80.2M 0.02% 821
2020
Q4 		$6.4M Buy
+68,600
New +$5.47M ﹤0.01% 2828

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs's ARKG Position: Q2 2026 in Review

Goldman Sachs increased its ARK Genomic Revolution ETF (ARKG) stake by 5.6% in Q2 2026, buying an estimated $5.08M and bringing the position to 3,016,963 shares worth $127M. The position accounts for 0.01% of the portfolio, ranked #1054.

Goldman Sachs first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Goldman Sachs held 3,016,963 shares of ARK Genomic Revolution ETF worth $127M as of Q2 2026.
  • Goldman Sachs bought 159,569 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $5.08M.
  • ARK Genomic Revolution ETF made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1054 holding.
  • Goldman Sachs first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.